Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein

Abstract

The reactivities to individual U1 small nuclear ribonucleoprotein (snRNP) components and their relationship to clinical features in patients with anti-U1 snRNP antibodies were examined. We evaluated 114 patients with connective tissue disease whose sera were positive for anti-U1 snRNP antibodies, but negative for anti-Sm antibodies. Antibodies to the U1 snRNP polypeptides 70K, A, and C were detected using subunit-specific enzyme-linked immunosorbent assays and antibodies to U1 small nuclear RNA (snRNA) were identified by an immunoprecipitation assay using deproteinized HeLa cell extracts. The clinical features were retrospectively obtained by chart review and prospectively collected after study entry. The pattern of antibody reactivities to U1 snRNP components varied among patients. The frequency of anti-70K, anti-A, anti-C, and anti-U1 snRNA antibodies was 60%, 86%, 74%, and 46%, respectively. There was no relationship between each reactivity and the clinical findings, but the presence of reactivities to increasing numbers of U1 snRNP components was correlated with sclerodactyly, shortness of the sublingual frenulum, esophageal dysfunction, and a lack of persistent proteinurea (p < 0.05 for all comparisons). The detection of autoantibody reactivities to individual components of the U1 snRNP particle is potentially useful for predicting the clinical course in patients with connective tissue disease and anti-U1 snRNP antibodies. Lupus (2010) 19, 307—312.

Keywords

autoantibody U1 snRNP mixed connective tissue disease epitope-spreading

Get full access to this article

View all access options for this article.

References

Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 311-335.

Hoffman RW , Sharp GC , Deutscher SL Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease. Arthritis Rheum 1995; 38: 1837-1844.

Hoffman IE , Peene I. , Meheus L. , et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1155-1158.

Margaux J. , Hayem G. , Palazzo E. , et al. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus. Rev Rheum Engl Ed 1998; 65: 378-386.

Monneaux F. , Muller S. Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis Rheum 2002; 46: 1430-1438.

Greidinger EL , Hoffman RW The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B’/B proteins as predominant U1 RNP immunogens . Arthritis Rheum 2001; 44: 368-375.

Tan EM , Cohen AS , Fries JF , et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 ; 23: 581-590.

Bohan A. , Peter JB Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-407.

10.

Kasukawa R. , Tojo T. , Miyawaki S. , et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R , Sharp GC (eds), Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Excerpta Medicina; 1987 . p. 41-47.

11.

Wigley FM , Lima JA , Mayes M. , et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 2005; 52: 2125-2132.

12.

Forman MS , Nakamura M. , Mimori T. , et al. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum 1985; 28: 1356-1361.

13.

Matsumura M. , Ohosone Y. , Miyachi K. , et al. Novel autoantibodies directed against the common tertiary configuration of transfer RNA in a patient with interstitial lung disease. Arthritis Rheum 1996; 39: 1308-1312.

14.

Murakami A. , Kojima K. , Ohya K. , Imamura K. , Takasaki Y. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease. Arthritis Rheum 2002; 46: 3273-3282.

15.

Sharp GC , Irvin WS , Tan EM , Gould RG , Holman HR Mixed connective tissue disease- an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-159.

16.

Nimelstein SH , Brody S. , McShane D. , et al. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 1980; 59: 239-248.

17.

Kuwana M. , Okano Y. , Kaburaki J. , et al. Major histocompatibility complex class II gene associations with anti-U1 small nuclear ribonucleoprotein antibody. Relationship to immunoreactivity with individual constituent proteins. Arthritis Rheum 1995; 38: 396-405.

18.

Deshmukh US , Bagavant H. , Lewis J. , et al. Epitope spreading within lupus-associated ribonucleoprotein antigens. Clin Immunol 2005 ; 117: 112-120.

19.

Tsokos GC , Liossis SN Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 1999; 20: 119-124.

20.

Arbuckle MR , McClain MT , Rubertone MV , et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.